BSE Live
Oct 28, 16:01Prev. Close
1142.90
Open Price
1120.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Titan Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 156.45 | 164.07 | 144.00 | 123.55 | 122.46 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 156.45 | 164.07 | 144.00 | 123.55 | 122.46 | |
| Total Operating Revenues | 156.45 | 164.07 | 144.00 | 123.55 | 122.46 | |
| Other Income | 3.91 | 1.75 | 1.94 | 0.94 | 0.66 | |
| Total Revenue | 160.36 | 165.82 | 145.94 | 124.49 | 123.12 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 75.48 | 80.89 | 70.81 | 59.12 | 55.54 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 16.62 | 18.13 | 15.77 | 11.58 | 9.50 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -2.85 | -5.29 | -0.93 | -0.17 | -2.23 | |
| Employee Benefit Expenses | 26.38 | 23.71 | 18.21 | 14.33 | 12.04 | |
| Finance Costs | 0.80 | 1.17 | 0.75 | 0.78 | 1.28 | |
| Depreciation And Amortisation Expenses | 4.17 | 3.33 | 2.60 | 2.37 | 2.10 | |
| Other Expenses | 15.39 | 12.34 | 10.63 | 7.51 | 5.80 | |
| Total Expenses | 136.00 | 134.29 | 117.83 | 95.52 | 84.03 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 24.37 | 31.53 | 28.12 | 28.97 | 39.09 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.32 | |
| Profit/Loss Before Tax | 24.37 | 31.53 | 28.12 | 28.97 | 38.76 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 5.97 | 7.79 | 7.21 | 7.35 | 9.85 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.12 | 0.11 | -0.09 | -0.07 | 0.13 | |
| Tax For Earlier Years | 0.00 | -0.03 | -0.03 | 0.00 | 0.01 | |
| Total Tax Expenses | 6.10 | 7.87 | 7.09 | 7.28 | 9.99 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 18.27 | 23.66 | 21.02 | 21.68 | 28.77 | |
| Profit/Loss From Continuing Operations | 18.27 | 23.66 | 21.02 | 21.68 | 28.77 | |
| Profit/Loss For The Period | 18.27 | 23.66 | 21.02 | 21.68 | 28.77 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 22.11 | 28.64 | 25.44 | 26.24 | 34.82 | |
| Diluted EPS (Rs.) | 22.11 | 28.64 | 25.44 | 26.24 | 34.82 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.65 | 1.49 | 1.24 | 1.24 | 0.83 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 20.00 | 20.00 | 18.00 | 15.00 | 15.00 |
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017